[1] 李慧丽,卢雪峰,李娜.恩替卡韦联合前列地尔治疗乙型肝炎肝硬化腹水的效果观察.临床肝胆病杂志,2016,32:292-295. [2] Radojkovic M, Stojanovic M, Stanojevic G,et al.Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury. Braz J Med Biol Res,2017,50:e6185. [3] 李兰娟,任红.传染病学.第8版. 北京:人民卫生出版社,2013. [4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年更新版).临床肝胆病杂志,2015,31:1941-1960. [5] 王昊,靳永强.前列地尔联合特利加压素治疗肝硬化合并难治性肝腹水的临床效果.四川医学,2018,39:47-51. [6] Ma W, Tao L, Zhang W, et al.Xia-Yu-Xue Decoction Inhibits Intestinal Epithelial Cell Apoptosis in CCl4-Induced Liver Fibrosis.Cell Physiol Biochem,2017,44:333-344. [7] 龙志玲,邵泽勇,伍锡刚,等.前列地尔联合复方鳖甲软肝片治疗慢性乙型肝炎肝硬化的疗效观察.现代药物与临床,2018,33:137-138. [8] Goldaracena N, Echeverri J, Spetzler VN, et al.Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation. Liver Transpl, 2016,22:1573-1583. [9] Bharathan VK, Chandran B, Gopalakrishnan U, et al.Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.Liver Transpl,2016,22:1067-1074. |